Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

China SXT Pharmaceuticals (SXTC) Equity Ratio (2018 - 2025)

China SXT Pharmaceuticals has reported Equity Ratio over the past 8 years, most recently at 0.77 for Q3 2025.

  • For Q3 2025, Equity Ratio rose 58.29% year-over-year to 0.77; the TTM value through Sep 2025 reached 0.77, up 58.29%, while the annual FY2025 figure was 0.71, 18.32% up from the prior year.
  • Equity Ratio for Q3 2025 was 0.77 at China SXT Pharmaceuticals, up from 0.71 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.77 in Q3 2025 and troughed at 0.35 in Q3 2023.
  • A 5-year average of 0.56 and a median of 0.55 in 2023 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: crashed 48.16% in 2023 and later surged 58.29% in 2025.
  • Year by year, Equity Ratio stood at 0.61 in 2021, then grew by 10.34% to 0.67 in 2022, then crashed by 48.16% to 0.35 in 2023, then soared by 39.39% to 0.49 in 2024, then surged by 58.29% to 0.77 in 2025.
  • Business Quant data shows Equity Ratio for SXTC at 0.77 in Q3 2025, 0.71 in Q1 2025, and 0.49 in Q3 2024.